Berberine inhibits tumour growth in vivo and in vitro through suppressing the lincROR-Wnt/β-catenin regulatory axis in colorectal cancer

S Li, C Shi, W Fu, J Zhang - Journal of Pharmacy and …, 2023 - academic.oup.com
Background Berberine, a non-prescription medicine clinically applied for diarrhoea and
gastroenteritis. Recent studies have demonstrated that it possesses anti-tumour properties …

Berberine inhibits tumour growth in vivo and in vitro through suppressing the lincROR-Wnt/β-catenin regulatory axis in colorectal cancer

S Li, C Shi, W Fu, J Zhang - Journal of Pharmacy and …, 2023 - academic.oup.com
Background Berberine, a non-prescription medicine clinically applied for diarrhoea and
gastroenteritis. Recent studies have demonstrated that it possesses anti-tumour properties …

Berberine inhibits tumour growth in vivo and in vitro through suppressing the lincROR-Wnt/β-catenin regulatory axis in colorectal cancer.

S Li, C Shi, W Fu, J Zhang - Journal of Pharmacy & …, 2023 - search.ebscohost.com
Background: Berberine, a non-prescription medicine clinically applied for diarrhoea and
gastroenteritis. Recent studies have demonstrated that it possesses anti-tumour properties …

Berberine inhibits tumour growth in vivo and in vitro through suppressing the lincROR-Wnt/β-catenin regulatory axis in colorectal cancer.

SY Li, CJ Shi, WM Fu, JF Zhang - 2023 - cabidigitallibrary.org
Background: Berberine, a non-prescription medicine clinically applied for diarrhoea and
gastroenteritis. Recent studies have demonstrated that it possesses anti-tumour properties …

Berberine inhibits tumour growth in vivo and in vitro through suppressing the lincROR-Wnt/β-catenin regulatory axis in colorectal cancer

SY Li, CJ Shi, WM Fu, JF Zhang - The Journal of …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Berberine, a non-prescription medicine clinically applied for diarrhoea and
gastroenteritis. Recent studies have demonstrated that it possesses anti-tumour properties …

Berberine inhibits tumour growth in vivo and in vitro through suppressing the lincROR-Wnt/β-catenin regulatory axis in colorectal cancer.

SY Li, CJ Shi, WM Fu, JF Zhang - The Journal of Pharmacy and …, 2022 - europepmc.org
Background Berberine, a non-prescription medicine clinically applied for diarrhoea and
gastroenteritis. Recent studies have demonstrated that it possesses anti-tumour properties …